Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Y009589 | — |
No additional AE; HBP calling reporting that a patient received an improperly stored PROQUAD. Reference TE case #02780764. HBP reported that the PROQUAD underwent a TE on 03/06/2025. HBP reported that the date of the administration was 03/27/2025. No symptoms or side; Information has been received from Business Partner/CRO on 01-Apr-2025. This spontaneous report was received from a Other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 27-Mar-2025, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y009589, expiration date: 17-Nov-2025) 0.5 mL for prophylaxis. On 27-Mar-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), (lot # and expiration date were not reported) for prophylaxis. This vaccination underwent temperature excursion in 39.44 Fahrenheit for 1 hour 35 minutes (Product storage error). No additional adverse event was reported.